Drug intelligence / Profile preview

Hylatopic

Development stage
Unknown
Lead developer
Collegium Pharmaceutical
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

**Hylatopic** is a prescription topical emollient foam, cream, and lotion formulation designed for skin barrier repair and hydration. It contains key ingredients such as **hydroxypropyl bispalmitamide MEA (a ceramide analog)**, **sodium hyaluronate**, **glycerin**, **petrolatum**, and **tocopheryl acetate**, which moisturize the skin, reduce itching and irritation, and support epidermal barrier function in conditions like dry skin, dermatitis (including atopic and radiation-induced), and various dermatoses. Developed initially by Collegium Pharmaceutical and later commercialized by specialty dermatology companies including Encore Dermatology and Onset Therapeutics, it is applied topically 3 times daily or as needed, with occlusion possible on broken skin, and is classified by the FDA as a hydrogel wound and burn dressing with drug/biologic components.[1][3][5][9][10]

Brand names
HylatopicHylatopicPlus

Beyond the preview

Go deeper on Hylatopic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hylatopic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call